Outcome of patients with pre-existing hepatitis B virus infection following renal transplant
Malhotra, K.K.; Dash, S.C.; Sharma, R.K.; Dhawan, I.K.; Mehta, S.N.; Tiwari, S.C.; Agarwal, S.K.; Bhuyan, U.N.
Tropical Gastroenterology Official Journal of the Digestive Diseases Foundation 14(1): 16-20
1993
ISSN/ISBN: 0250-636X PMID: 8342244 Document Number: 416412
Twenty four patients who were HBsAg positive prior to renal transplantation were studied with respect to their hepatic and renal outcome. The kidneys in all patients were obtained from living related donors. The standard immunosuppressive therapy consisted of azathioprine and prednisolone. Post-renal transplant follow-up varied from 32-86 months (mean 55 +/- 9). Renal functions, liver functions, HBsAg and HBsAb status was closely monitored during follow-up. One patient developed acute hepatitis four months after transplantation; this resolved in 10 weeks. Four patients showed transient elevations of liver enzymes. The results of liver biopsy in 16 cases revealed, normal histology (8), virus in hepatocytes (5), and acute hepatitis (3). None of the patients had evidence of chronic liver disease. Two patients died due to chronic rejection/chronic renal failure and two patients died due to septicaemia. Five living patients have mild to moderate chronic rejection. It was concluded that pre-existing HBsAg carrier state in transplant patients had no deteriorating effect on the liver. The mortality was related to chronic rejection and septicaemia.